ADBE - beat this quarter and set guidance below est. short eye on the 32 fail, with tgt at 31's. Specifically announced Q2 revenue of $1.12 bln, in line to just above the analyst
consensus of $1.10
bln on Capital IQ. EPS was $0.60, vs.
expectations of $0.59 per share; narrowed its annual revenue
growth target to a range of six to seven percent, versus its prior target range
of six to eight percent.
IDIX - Announced results from an ongoing phase IIb study of IDX184 in
combination with pegylated interferon and ribavirin (PegIFN/RBV). Nice move up ah's, will be in play tomorrow. Could pull to 10.3's initially then be a long idea.
JBL - Q3 revenue of $4.3 bln, just ahead of the analyst consensus of
$4.28
bln on Capital IQ. EPS was $0.64, in line with
expectations. Prolly a range trader, let it establish, then trade accordingly.
FSII - Reported Q3 2012 sales of $50.8 million, a 98%
jump compared to $25.6
million for the same period in fiscal 2011. This outlook downgrade/miss is bs imo, I think they are playing a game, let it set up long, take the trade, with low established.
BODY - sick move today, called this one off lows, didn't take it, ah VELT all over again, eying tommorrow, i think we see a 10 mag swing.
ARNA - great trader today, banked much $. We'll see tomorrow, short bias on morning rush.
PVA - short bias on crack of sup.
